Kevin A. Janes
- Pharmaceutical Science top 0.2%
- Biomaterials top 0.5%
- Molecular Biology top 2%
- Gene Regulatory Network Analysis 15
- Bioinformatics and Genomic Networks 8
- Single-cell and spatial transcriptomics 6
- Molecular Medicine top 2%
- Surfaces, Coatings and Films top 2%
-
- Cell Image Analysis Techniques 10
-
- Cancer Cells and Metastasis 8
-
- Computational Drug Discovery Methods 8
-
- Viral Infections and Immunology Research 6
-
- interferon and immune responses 5
- Co-authors
- Marı́a José AlonsoDouglas A. LauffenburgerMichael B. YaffePilar CalvoPeter K. SorgerJohn G. AlbeckSuzanne GaudetKam W. Leong
- Partner nations
- United StatesSpainUnited Kingdom
In The Last Decade
Kevin A. Janes
63 papers receiving 5.7k citations
Hit Papers
Peers
Comparison fields: 5 of 158
- Pharmaceutical Science 1.2k
- Biomaterials 1.2k
- Molecular Biology 3.3k
- Molecular Medicine 237
- Surfaces, Coatings and Films 323
Countries citing papers authored by Kevin A. Janes
This map shows the geographic impact of Kevin A. Janes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin A. Janes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin A. Janes more than expected).
Fields of papers citing papers by Kevin A. Janes
This network shows the impact of papers produced by Kevin A. Janes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin A. Janes. The network helps show where Kevin A. Janes may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kevin A. Janes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 4 | |
| 5 | 2021 | 16 | |
| 6 | 2020 | 25 | |
| 7 | 2020 | 25 | |
| 8 | 2020 | 93 | |
| 9 | 2018 | 88 | |
| 10 | 2017 | 60 | |
| 11 | 2016 | 18 | |
| 12 | 2013 | 20 | |
| 13 | 2013 | 35 | |
| 14 | 2012 | 12 | |
| 15 | 2011 | 50 | |
| 16 | 2010 | 83 | |
| 17 | 2008 | 80 | |
| 18 | 2006 | 83 | |
| 19 | 2003 | 85 | |
| 20 | 1989 | 34 |
About Kevin A. Janes
Kevin A. Janes is a scholar working on Biophysics, Molecular Biology and Pharmaceutical Science, having authored 65 papers that have together received 5.8k indexed citations. Recurring topics across this work include Gene Regulatory Network Analysis (15 papers), Cell Image Analysis Techniques (10 papers), Cancer Cells and Metastasis (8 papers), Computational Drug Discovery Methods (8 papers), Bioinformatics and Genomic Networks (8 papers), Single-cell and spatial transcriptomics (6 papers), Viral Infections and Immunology Research (6 papers) and interferon and immune responses (5 papers). The work is most often cited by research in Pharmaceutical Science (1.2k citations), Biomaterials (1.2k citations) and Molecular Biology (3.3k citations). Kevin A. Janes has collaborated with scholars based in United States, Spain and United Kingdom. Frequent co-authors include Marı́a José Alonso, Douglas A. Lauffenburger, Michael B. Yaffe, Pilar Calvo, Peter K. Sorger, John G. Albeck, Suzanne Gaudet, Kam W. Leong, Hai‐Quan Mao and J. Thomas August. Their work appears in journals such as Nature, Science and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.